Abiopharma

Real Opens Investor Q&A Portal Ahead of First Quarter 2026 Financial Results

ZIM to Release First Quarter 2026 Results on Wednesday, May 20, 2026

FORUM PROVIDES UPDATE ON SHARE REPURCHASE PROGRAM

Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

Federal Signal Reports First Quarter Results Including 35% Net Sales Growth, 52% Operating Income Improvement, and Strong Cash Generation; Raises Full-Year Outlook and Increases EBITDA Margin Targets for Safety and Security Systems Group

SS&C Unveils WorkHQ to Power Enterprise Agentic Automation

Incyte to Present at Upcoming Investor Conferences

The Radoff-JEC Group Responds to Seer, Inc.’s Rejection of April 24th Acquisition Proposal

Western Asset Global Corporate Opportunity Fund Inc. Announces Results of Annual Meeting of Stockholders

Fully Booked Momentus Mission Advances Through Preliminary Design Review, Driving Toward 2027 Launch Under NASA Contracts